読み込み中
NASDAQHealthcareMedical - Diagnostics & Research
最新データ
$267.76
−$5.78 · -2.11%
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They also offer instrument maintenance agreements, collaborate through development and licensing deals, and perform cancer detection tests. Its diverse clientele comprises leading genomic research facilities, universities, state-funded laboratories, medical centers, pharmaceutical and biotechnology firms, commercial molecular diagnostic providers, and businesses focused on consumer genomics. Illumina employs a two-pronged distribution strategy, selling directly to clients across North America, Europe, Latin America, and the Asia-Pacific. Additionally, it partners with life-science distributors to reach markets in Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.
前日終値
$267.76
−$5.78 · -2.11%
市場前
$264
−$3.76 · -1.40%
10月8日 9:27 ET
日中の時刻はETです。市場データは遅延する場合があります。
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They also offer instrument maintenance agreements, collaborate through development and licensing deals, and perform cancer detection tests. Its diverse clientele comprises leading genomic research facilities, universities, state-funded laboratories, medical centers, pharmaceutical and biotechnology firms, commercial molecular diagnostic providers, and businesses focused on consumer genomics. Illumina employs a two-pronged distribution strategy, selling directly to clients across North America, Europe, Latin America, and the Asia-Pacific. Additionally, it partners with life-science distributors to reach markets in Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.
日中レンジ
現在 $267.76
52週レンジ
現在 $267.76
日中の時刻はETです。市場データは遅延する場合があります。
GoAI スコア
買い
バリュエーション
84
大幅な割安
センチメント
54
まちまち
リスク
38
中程度のリスク
モメンタム
72
上昇基調
GoAIの詳細リサーチ
詳しい根拠、カタリスト、リスクを確認できます。
Illumina, Inc. specializes in delivering advanced genetic and genomic analysis tools, primarily through sequencing and array technologies. The company's offerings empower clients across various sectors to integrate genomic insights into both research and clinical environments, with applications spanning critical fields like life sciences, cancer diagnostics, reproductive health, agriculture, and innovative new domains. Illumina's portfolio encompasses specialized instrumentation and necessary consumables for genetic analysis, alongside comprehensive genotyping and sequencing services. They also offer instrument maintenance agreements, collaborate through development and licensing deals, and perform cancer detection tests. Its diverse clientele comprises leading genomic research facilities, universities, state-funded laboratories, medical centers, pharmaceutical and biotechnology firms, commercial molecular diagnostic providers, and businesses focused on consumer genomics. Illumina employs a two-pronged distribution strategy, selling directly to clients across North America, Europe, Latin America, and the Asia-Pacific. Additionally, it partners with life-science distributors to reach markets in Europe, the Asia-Pacific, Latin America, the Middle East, and Africa. Established in 1998, the company maintains its corporate headquarters in San Diego, California.
日中レンジ
現在 $267.76
52週レンジ
現在 $267.76
利用可能な期間全体で報告されたマージン。
売上高
営業利益
純利益
| 指標（USD） | 2025年度 | 2024年度 | 2023年度 | 2022年度 | 2021年度 |
|---|---|---|---|---|---|
| 売上高 | 43.38億 USD | 43.72億 USD | 45.04億 USD | 45.84億 USD | 45.26億 USD |
| 売上原価 | 14.45億 USD | 15.11億 USD | 17.6億 USD | 16.12億 USD | 13.72億 USD |
| 粗利益 | 28.93億 USD | 28.61億 USD | 27.44億 USD | 29.72億 USD | 31.54億 USD |
| 研究開発 | 9.51億 USD | 11.69億 USD | 13.54億 USD | 13.21億 USD | 11.85億 USD |
| 販売・一般管理 | 10.78億 USD | 10.92億 USD | 16.12億 USD | 12.97億 USD | 20.92億 USD |
| 営業費用 | 20.29億 USD | 36.94億 USD | 38.13億 USD | 71.51億 USD | 32.77億 USD |
| 受取利息 | 4000万 USD | 4600万 USD | 5800万 USD | 1100万 USD | — |
| 支払利息 | 1.01億 USD | 1億 USD | 7700万 USD | 2600万 USD | 6100万 USD |
| 減価償却費と償却費 | 2.7億 USD | 3.54億 USD | 4.32億 USD | 3.94億 USD | 2.51億 USD |
| 営業利益 | 8.64億 USD | −8.33億 USD | −10.69億 USD | −41.79億 USD | −1.23億 USD |
| 純利益 | 8.5億 USD | −12.23億 USD | −11.61億 USD | −44.04億 USD | 7.62億 USD |
会社概要が更新されました 2026年10月8日.
AIが生成した遅延市場データを、情報提供および教育目的で掲載しています。投資助言ではありません。